Toxicology and Pharmacology

Biography

Dr. Ghantous joined the US Food and Drug Administration as a pharmacology/toxicology reviewer in 2001, and since 2007 she has been the Pharmacology/Toxicology supervisor at the Division of Antiviral Products, Center for Drug Evaluation and Research. Dr. Ghantous has presented at national and international scientific and regulatory meetings, has served on several US FDA committees, has been involved in writing Guidance documents and has represented the Agency at various public forums. Before coming to FDA, Dr. Ghantous worked for approximately 10 years at the DuPont Company. She has been a member of the Society of Toxicology since 1989 and the American College of Toxicology since 2000. She served on the Continuing Education Committee of the Society of Toxicology (2010–2013). Dr. Ghantous is one of the founders of the Biotechnology Specialty Section and served as a VP- elect, VP, President and past president of the specialty section (2010-2013). She also served as a member of the Board of Directors of the American Board of Toxicology (2010–2014) and was the president of the board for 2013-2014. She also served on council of the American College of Toxicology (2011-2013) and is the president of the American College of Toxicology (2015-2016). Dr. Ghantous received a B.Sc. in Pharmacy from the University of Baghdad, Iraq, an M.Sc. in Pharmacology from the University of Strathclyde, Scotland and a PhD in Toxicology from the University of Uppsala, Sweden. She was a postdoctoral fellow in the Department of Anesthesiology, University of Arizona, and received her board certification as a Diplomate of the American Board of Toxicology (DABT) in 1995. Dr. Ghantous has over 20 years of combined experience in general and regulatory toxicology and has published pier reviewed scientific papers and book chapters.

Research Interest

Hanan Ghantous’s fields of research interest include Toxicology and Pharmacology.